{"id":"W4403505143","doi":"10.1016/j.esmoop.2024.103937","title":"Response to: Cholangiocarcinoma patients with FGFR2 fusions/rearrangements but primary refractory to pemigatinib: the real challenge?","year":2024,"lang":"en","type":"letter","venue":"ESMO Open","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medac; BeiGene; Ipsen; Incyte; Eisai; Sanofi; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Servier; Amgen","keywords":"Refractory (planetary science); Primary (astronomy); Cancer research; Medicine; Internal medicine; Oncology; Biology; Astrobiology; Physics; Astrophysics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008923579,0.0007758689,0.001380416,0.0006683544,0.002097442,0.001893422,0.001135076,0.02909327,0.007354253],"category_scores_gemma":[0.00914465,0.00042659,0.001129374,0.000488452,0.001440558,0.001924274,0.0009989695,0.0178699,0.005392828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003035898,"about_ca_system_score_gemma":0.001667786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00328745,"about_ca_topic_score_gemma":0.004875205,"domain_scores_codex":[0.9990043,0.0002374836,0.0001326893,0.0001477869,0.0002303285,0.0002474017],"domain_scores_gemma":[0.9978636,0.0008130103,0.0001624271,0.0000654079,0.0003940755,0.0007015876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001835895,0.00006676303,0.002444846,0.00008237689,0.00002555626,0.02316447,0.00008190508,0.0002289864,0.0003365154,0.001473668,0.96205,0.009861311],"study_design_scores_gemma":[0.000764206,0.0003727239,0.007170443,0.0009418721,0.0001251302,0.05297028,0.001080201,0.002529396,0.000656173,0.0159077,0.9172708,0.0002109585],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001291444,0.001102281,0.0001250624,0.9791219,0.01479442,0.00002489082,0.0001324281,0.00004660465,0.003361013],"genre_scores_gemma":[0.01615072,0.001842405,0.0004619046,0.9116693,0.06068617,0.00006411837,0.0001673661,0.00004762828,0.008910426],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02909327,"threshold_uncertainty_score":0.02460247,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02058377810227568,"score_gpt":0.2860546329042308,"score_spread":0.2654708548019551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}